---
figid: PMC7479251__fonc-10-01533-g0003
figtitle: NFKB pathway including targets and drugs that could be employed to inhibit
  it
organisms:
- NA
pmcid: PMC7479251
filename: fonc-10-01533-g0003.jpg
figlink: pmc/articles/PMC7479251/figure/F3/
number: F3
caption: NF-κB pathway including targets and drugs that could be employed to inhibit
  it. (Left) canonical NF-κB signaling. (Right) non-canonical NF-κB signaling.
papertitle: Therapeutic Targeting of Signaling Pathways Related to Cancer Stemness.
reftext: Asunción Espinosa-Sánchez, et al. Front Oncol. 2020;10:1533.
year: '2020'
doi: .na.character
journal_title: .na.character
journal_nlm_ta: .na.character
publisher_name: .na.character
keywords: .na.character
automl_pathway: 0.9386135
figid_alias: PMC7479251__F3
figtype: Figure
organisms_ner:
- NA
redirect_from: /figures/PMC7479251__F3
ndex: ''
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC7479251__fonc-10-01533-g0003.html
  '@type': Dataset
  description: NF-κB pathway including targets and drugs that could be employed to
    inhibit it. (Left) canonical NF-κB signaling. (Right) non-canonical NF-κB signaling.
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - Thalidomide
  - Bortezomib
  - BMS-345541
---
